Epirubicine-vinorelbine (EV) intravenous combination followed by oral vinorelbine (VNR) as first-line treatment in advanced breast cancer (ABC) patients: A POLONORD Group study

Authors :: L. Isa
Daniele Fagnani
Antonio Ardizzoia
Luciano Frontini
Monica Giordano
Alessandro Bertolini
G. Scognamiglio
A. Scanni
T. Pressiani
I. Colombo
Source :: Journal of Clinical Oncology. 23:770-770
Publication Year :: 2005
Publisher :: American Society of Clinical Oncology (ASCO), 2005.
Abstract: 770 Background: Epirubicin and Vinorelbine alone or in combination are considered active in ABC.The optimal duration of a chemotherapic treatment in ABC patients is not know. Otherwise Epirubicin h...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Group study
business.industry
Advanced breast
Cancer
Vinorelbine
medicine.disease
Surgery
carbohydrates (lipids)
First line treatment
Internal medicine
polycyclic compounds
medicine
skin and connective tissue diseases
business
medicine.drug
Epirubicin

Tools